FIELD: medicine.
SUBSTANCE: invention refers to medicine and represents a method for preparing a therapeutic radioconjugate of a specifically binding agent with a short-lived radionuclide for the delivery to pathological regions. Implementing the method involves labelling recombinant humanised mini-antibodies specific to the cancer-associated antigen HER2/neu, with the diagnostic gamma-ray radionuclide aquacarbonyl complex Tc-99m; the mini-antibodies are conjugated with human albumin; the prepared conjugate is purified and added with the chelating agent DOTA (1,4,7,10-tetraazacyclododecane tetraacetic acid) or DTPA (diethylene triamine pentaacetic acid); the prepared conjugate is labelled with the therapeutic alpha-ray radionuclides; and the produced preparation is purified.
EFFECT: producing the anti-cancer preparation possessing a low risk of the conflict with the immune system, simplifying the formulation and providing a demand for preparations with targeted agent delivery.
6 cl, 1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING COMPLEX OF TECHNETIUM-99m WITH RECOMBINANT PROTEIN-TARGETED MOLECULES FOR RADIONUCLIDE DIAGNOSIS OF ONCOLOGICAL DISEASES WITH HER-2/neu OVEREXPRESSION | 2018 |
|
RU2684289C1 |
METHOD OF OBTAINING SET OF TECHNETIUM-99M COMPLEX WITH THE MODIFIED SPECIFIC MINI-ANTIBODIES FOR DIAGNOSTICS OF ONCOLOGICAL DISEASES WITH HER2/NEU OVEREXPRESSION | 2016 |
|
RU2655965C2 |
METHODS FOR PRODUCING RADIOIMMUNOCONJUGATES | 2010 |
|
RU2704802C2 |
METHODS FOR PRODUCING RADIOIMMUNOCONJUGATES | 2010 |
|
RU2565402C2 |
METHOD FOR PRODUCING RADIOLABELLED CALCIUM CARBONATE PARTICLES USING DEFEROXAMINE AS CHELATING AGENT | 2022 |
|
RU2806148C1 |
NOVEL RADIOIMMUNOCONJUGATES AND USE THEREOF | 2011 |
|
RU2664475C1 |
METHOD FOR PRODUCING RADIOLABELLED CALCIUM CARBONATE PARTICLES USING TETRAXETAN AS CHELATING AGENT | 2022 |
|
RU2806147C1 |
NOVEL RADIOIMMUNOCONJUGATES AND THEIR APPLICATIONS | 2011 |
|
RU2560587C9 |
RADIOPHARMACEUTICAL SOLUTIONS WITH PREFERRED PROPERTIES | 2016 |
|
RU2741794C2 |
POLYPEPTIDES | 2011 |
|
RU2577964C2 |
Authors
Dates
2014-12-27—Published
2013-03-26—Filed